ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 041,66
-1,12%
Dow Jones
38 932,50
-0,35%
DAX
18 639,96
-0,65%
Brent Oil
83,53
0,83%
Bitcoin
68 016,64
-1,98%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Eyetech Pharmaceuticals (MM) (EYET)

  7. Eyetech Pharmaceuticals (MM) (EYET) Actualités

EYET

Eyetech (EYET)

Eyetech Pharmaceuticals (MM)
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:EYET
DateHeureSourceTitreSymboleSociété
12/11/200523h52Business WireOSI Pharmaceuticals and Eyetech Pharmaceuticals Confirm November 14th ClosingNASDAQ:EYETEyetech Pharmaceuticals (MM)
10/11/200517h30PR Newswire (US)Eyetech Provides Update on Status of Pending Acquisition by OSI PharmaceuticalsNASDAQ:EYETEyetech Pharmaceuticals (MM)
31/10/200523h00PR Newswire (US)Eyetech Reports Third Quarter 2005 Financial ResultsNASDAQ:EYETEyetech Pharmaceuticals (MM)
17/10/200515h30PR Newswire (US)Eyetech Announces Enrollment of the First Patient in a Phase 3 Clinical Trial of Macugen(R) (pegaptanib sodium injection) in DiaNASDAQ:EYETEyetech Pharmaceuticals (MM)
05/10/200515h30PR Newswire (US)Recent Analyses Suggest That Treatment With Macugen(R) (pegaptanib sodium injection) May Provide Better Results for Patients WitNASDAQ:EYETEyetech Pharmaceuticals (MM)
16/09/200515h15PR Newswire (US)Macugen(R) (pegaptanib sodium injection) Receives Positive Opinion for Treatment of Neovascular Age-Related Macular DegenerationNASDAQ:EYETEyetech Pharmaceuticals (MM)
22/08/200502h48PR Newswire (US)OSI Pharmaceuticals and Eyetech Pharmaceuticals Announce Signing of Definitive Merger AgreementNASDAQ:EYET
22/08/200501h45Business WireOSI Pharmaceuticals and Eyetech Pharmaceuticals Announce Signing of Definitive Merger Agreement; Acquisition Projected to be AccNASDAQ:EYETEyetech Pharmaceuticals (MM)
09/08/200515h30PR Newswire (US)Macugen(R) (pegaptanib sodium injection) Named Innovative Pharmaceutical Product Of The Year At The 2005 Pharmaceutical AchievemNASDAQ:EYETEyetech Pharmaceuticals (MM)
27/07/200523h30PR Newswire (US)Eyetech Reports Second Quarter 2005 Financial ResultsNASDAQ:EYETEyetech Pharmaceuticals (MM)
18/07/200520h30PR Newswire (US)Eyetech and Pfizer Comment on Data Presented at Meeting of Retinal SpecialistsNASDAQ:EYET
15/07/200519h30PR Newswire (US)Eyetech To Announce Second Quarter 2005 Financial Results On July 27, 2005NASDAQ:EYETEyetech Pharmaceuticals (MM)
22/06/200514h30PR Newswire (US)Eyetech Raises Full-Year Sales Forecast for Macugen(R) (pegaptanib sodium injection)NASDAQ:EYETEyetech Pharmaceuticals (MM)
21/06/200521h33PR Newswire (US)Eyetech Vision Day to Preview Future of Macugen FranchiseNASDAQ:EYET
14/06/200501h34PR Newswire (US)Eyetech to Host Vision Day on Wednesday, June 22NASDAQ:EYETEyetech Pharmaceuticals (MM)
10/06/200523h29Business WireSchaeffer's Midday Options Update Features General Motors, Citigroup, Northrop Grumman, Intel, and Eyetech PharmaceuticalsNASDAQ:EYETEyetech Pharmaceuticals (MM)
10/06/200514h31PR Newswire (US)Eyetech Announces Appointment of Henry Simon as Chairman of the Board and Resignation of John McLaughlinNASDAQ:EYETEyetech Pharmaceuticals (MM)
09/06/200514h30PR Newswire (US)Eyetech Adopts Stockholder Rights AgreementNASDAQ:EYETEyetech Pharmaceuticals (MM)
25/05/200503h30PR Newswire (US)Eyetech Announces Conference Call to Reiterate Confidence in Macugen(R) (Pegaptanib Sodium Injection)NASDAQ:EYETEyetech Pharmaceuticals (MM)
24/05/200514h30PR Newswire (US)Eyetech Announces Approval of Macugen(R) in Brazil for the Treatment of Neovascular (Wet) Age-Related Macular DegenerationNASDAQ:EYETEyetech Pharmaceuticals (MM)
11/05/200500h30PR Newswire (US)Eyetech to Present at the 2005 UBS Global Pharmaceuticals ConferenceNASDAQ:EYETEyetech Pharmaceuticals (MM)
05/05/200523h10PR Newswire (US)Eyetech Announces Approval of Macugen(R) in Canada for The Treatment of Neovascular (Wet) Age Related Macular DegenerationNASDAQ:EYETEyetech Pharmaceuticals (MM)
05/05/200516h19PR Newswire (US)Macugen(R) (pegaptanib sodium injection) Studied in Treatment of Diabetic Macular Edema (DME) and Other Diabetic Retinopathy LesNASDAQ:EYETEyetech Pharmaceuticals (MM)
02/05/200523h10PR Newswire (US)Preclinical Study Demonstrates Significance of VEGF164 in Pathological NeovascularizationNASDAQ:EYETEyetech Pharmaceuticals (MM)
02/05/200523h10PR Newswire (US)Safety Profile of Macugen(R) (pegaptanib sodium injection) in the Treatment of Neovascular Age-Related Macular Degeneration (AMDNASDAQ:EYETEyetech Pharmaceuticals (MM)
21/04/200523h30PR Newswire (US)Eyetech to Present at Morgan Stanley's Third Annual Global Healthcare Unplugged ConferenceNASDAQ:EYETEyetech Pharmaceuticals (MM)
21/04/200500h09PR Newswire (US)Eyetech Reports First Quarter 2005 Financial ResultsNASDAQ:EYETEyetech Pharmaceuticals (MM)
07/04/200523h30PR Newswire (US)Eyetech Announces Co-Founder Marty Glick Steps Down From Board To Act As ConsultantNASDAQ:EYETEyetech Pharmaceuticals (MM)
07/04/200523h30PR Newswire (US)Eyetech to Announce First Quarter 2005 Financial Results on April 20, 2005NASDAQ:EYETEyetech Pharmaceuticals (MM)
18/03/200522h15PR Newswire (US)Eyetech to Present at the Eighth Annual Lehman Brothers Global Healthcare ConferenceNASDAQ:EYETEyetech Pharmaceuticals (MM)
 Showing the most relevant articles for your search:NASDAQ:EYET

Dernières Valeurs Consultées

LSE
DPD
LATK
SUNETH
USOTC
AAGFF
Aftermath Silver (QX)
KOSPI
093370
Foosung
COIN
BIZBTC
USOTC
OCESP
Ocean Spray Cran (CE)
USOTC
CEAYY
China Eastern Airlines (PK)
BOV
BRHT11
Fundo Investimento Imobi...
NASDAQ
EQOSW
Diginex
BATSI
BUKALT
BOV
E2TS34
Etsy
USOTC
CRBAF
Carbeeza (QB)
NYSE
BBLN
Babylon
NASDAQ
AAYTRXX
Barclays Bank Plc Issuer...
NASDAQ
FLRZEX
Dow 30 Buywrite Portfoli...
LSE
TRIA
Ivz 0-1 Acc Usd
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés